Natural history with risk of progression of mGUs and smouldering... | Download Table
Absolute Risk of Progression of MGUS to Myeloma or Related Disorders... | Download Table
Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma - Donk - 2016 - International Journal of Laboratory Hematology - Wiley Online Library
How I Treat In Brief: Managing Monoclonal Gammopathy of Undetermined Significance
What is the significance of monoclonal gammopathy of undetermined significance? | RCP Journals
Monoclonal gammopathy and primary care | British Columbia Medical Journal
How to Diagnose Monoclonal Gammopathy of Undetermined Significance – Consult QD
Monoclonal gammopathy of undetermined significance: Using risk stratification to guide follow-up | MDedge Family Medicine
How I manage monoclonal gammopathy of undetermined significance - ScienceDirect
An approach to the diagnosis and management of multiple myeloma
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum Free Light Chain Assessment in Monoclonal Gammopathy and Kidney Disease
247 SPEP It Up - The Curbsiders
JPM | Free Full-Text | Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.,JAMA Oncology - X-MOL
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement | Blood Cancer Journal
Frontiers | Case Report: Monoclonal Gammopathies of Clinical Significance-Associated Myopathy: A Case-Based Review
Risk Stratifying Patients with Monoclonal Gammopathy of Undetermined Significance – Consult QD
Final Diagnosis -- Case 569
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Vincent Rajkumar on Twitter: "Monoclonal Gammopathy of Undetermined Significance (MGUS). Present in ~5% of all people age 50+ Therefore something all clinicians should know about. Brief summary. #medtwitter @ESHaematology 1/ https://t.co/VyhxekBiTe" /
Serum free light chain ratio predicts outcome in MGUS | Semantic Scholar
The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied? | Blood Cancer Journal
MGUS — HaemBase
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
Suggested algorithm for bone marrow biopsy and skeletal ... | GrepMed
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
